Do Not Use Systemic Steroids for the Common Cold
Systemic corticosteroids should NOT be used to treat an uncomplicated common cold. The evidence clearly demonstrates no meaningful benefit for symptom relief, while exposing patients to unnecessary risks including potential immunosuppression and enhanced viral replication.
Evidence-Based Rationale
Guideline Consensus Against Use
The most authoritative guidelines uniformly advise against systemic corticosteroids for common cold and post-viral rhinosinusitis:
The EPOS 2020 guideline explicitly advises against systemic corticosteroids for acute post-viral rhinosinusitis (which includes common cold presentations) 1. Their analysis of four double-blind placebo-controlled studies found:
- No positive effect on recovery at 7-14 days
- Only a small, clinically insignificant effect on facial pain at days 4-7 (number needed to treat = 11)
- No effect on nasal discharge resolution
- High spontaneous recovery rates (72% with placebo alone)
The 2025 AAO-HNS Adult Sinusitis guideline similarly found that oral steroids as monotherapy showed no benefit over placebo, with only modest short-term effects when combined with antibiotics (NNT = 7), but with significant risk of attrition bias 2
French official guidelines (2003) state unequivocally that antibiotic treatment is not justified in uncomplicated common cold, and by extension, neither are systemic steroids 3
Research Evidence Shows Harm Without Benefit
The highest quality research demonstrates concerning findings:
A 1996 experimental rhinovirus study found that oral prednisone (20 mg three times daily):
- Reduced kinin levels but provided no significant reduction in total symptom scores 4
- Increased viral titers (mean 1.13 vs 0.79, p=0.03) with significant differences on days 3-4
- Enhanced viral growth in steroid recipients
- Increased sneezing and mucus production on day 1
Cochrane systematic reviews (2012,2015) examining intranasal corticosteroids found no benefit for duration or severity of common cold symptoms 5, 6. While these examined intranasal rather than systemic steroids, the lack of efficacy is notable.
Why Steroids Don't Work and May Harm
The common cold is a self-limiting viral illness that resolves spontaneously in 7-10 days 3. Systemic corticosteroids:
- Suppress immune response needed to clear viral infection 4, 7
- Enhance viral replication as demonstrated in controlled trials 4
- Provide no clinically meaningful symptom relief despite anti-inflammatory effects 1
- Expose patients to unnecessary adverse effects including metabolic changes, immunosuppression, and gastrointestinal symptoms 2, 7
What to Do Instead
Symptomatic management only:
- Analgesics (acetaminophen or NSAIDs) for pain and fever 8, 9
- First-generation antihistamine/decongestant combinations may provide modest benefit 10
- Nasal saline irrigation (optional, low risk) 2
- Patient education about viral etiology, expected 7-10 day duration, and self-limiting nature 3
Critical Pitfalls to Avoid
Do not confuse common cold with acute bacterial rhinosinusitis (ABRS): ABRS requires symptoms persisting ≥10 days or worsening after initial improvement ("double worsening") 2, 9
Do not use purulent nasal discharge color as indication for steroids or antibiotics: Neutrophils cause colored discharge in viral infections without bacterial involvement 9
Do not prescribe steroids to "prevent complications": No evidence supports this practice 3
Recognize that even the modest benefits seen in some studies (facial pain at 4-7 days) are offset by the number needed to treat (11-14) and potential harms 1
The evidence quality is moderate to low, but the consistent finding across multiple guidelines and research studies is clear: systemic corticosteroids have no role in treating uncomplicated common cold 1, 3, 1.